Pictet Asset Management Holding SA »

Akebia Therapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2025-09-30 $73k 27k 2.73

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corp Call Call Option (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Amazon Call Call Option (AMZN)
Broadcom Call Call Option (AVGO)
Ubs Group SHS (UBS)
Thermo Fisher Scientific (TMO)
Meta Platforms Call Call Option (META)
Kla Corp Com New (KLAC)
Synopsys (SNPS)
Nxp Semiconductors N V (NXPI)
Ecolab (ECL)
Republic Services (RSG)
Tesla Call Call Option (TSLA)

View all positions for Pictet Asset Management Holding SA

Top funds holding Akebia Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Morgan Stanley
Renaissance Technologies
UBS Group
Citadel Advisors
Qube Research & Technologies
MPM Oncology Impact Management
Millennium Management
Franklin Resources
Northern Trust
Affinity Asset Advisors
Invesco

View all funds holding Akebia Therapeutics